These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 22227019)

  • 21. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
    Vilsbøll T; Christensen M; Junker AE; Knop FK; Gluud LL
    BMJ; 2012 Jan; 344():d7771. PubMed ID: 22236411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
    Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
    J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.
    Anderberg RH; Richard JE; Eerola K; López-Ferreras L; Banke E; Hansson C; Nissbrandt H; Berqquist F; Gribble FM; Reimann F; Wernstedt Asterholm I; Lamy CM; Skibicka KP
    Diabetes; 2017 Apr; 66(4):1062-1073. PubMed ID: 28057699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
    Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
    J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
    Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed.
    Alhadeff AL; Baird JP; Swick JC; Hayes MR; Grill HJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2233-43. PubMed ID: 24681814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis.
    Koehler JA; Baggio LL; Cao X; Abdulla T; Campbell JE; Secher T; Jelsing J; Larsen B; Drucker DJ
    Diabetes; 2015 Mar; 64(3):1046-56. PubMed ID: 25277394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
    Bojanowska E; Radziszewska E
    J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation.
    Hayes MR; Skibicka KP; Grill HJ
    Endocrinology; 2008 Aug; 149(8):4059-68. PubMed ID: 18420740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression.
    Wagner S; Brierley DI; Leeson-Payne A; Jiang W; Chianese R; Lam BYH; Dowsett GKC; Cristiano C; Lyons D; Reimann F; Gribble FM; Martinez de Morentin PB; Yeo GSH; Trapp S; Heisler LK
    Mol Metab; 2023 Feb; 68():101665. PubMed ID: 36592795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling.
    Mietlicki-Baase EG; Ortinski PI; Reiner DJ; Sinon CG; McCutcheon JE; Pierce RC; Roitman MF; Hayes MR
    J Neurosci; 2014 May; 34(20):6985-92. PubMed ID: 24828651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.
    Rupprecht LE; Mietlicki-Baase EG; Zimmer DJ; McGrath LE; Olivos DR; Hayes MR
    Am J Physiol Endocrinol Metab; 2013 Sep; 305(6):E751-9. PubMed ID: 23900416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E; Bojanowska E
    Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
    Secher A; Jelsing J; Baquero AF; Hecksher-Sørensen J; Cowley MA; Dalbøge LS; Hansen G; Grove KL; Pyke C; Raun K; Schäffer L; Tang-Christensen M; Verma S; Witgen BM; Vrang N; Bjerre Knudsen L
    J Clin Invest; 2014 Oct; 124(10):4473-88. PubMed ID: 25202980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.
    Yamamoto H; Kishi T; Lee CE; Choi BJ; Fang H; Hollenberg AN; Drucker DJ; Elmquist JK
    J Neurosci; 2003 Apr; 23(7):2939-46. PubMed ID: 12684481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
    Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
    Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.
    Beiroa D; Imbernon M; Gallego R; Senra A; Herranz D; Villarroya F; Serrano M; Fernø J; Salvador J; Escalada J; Dieguez C; Lopez M; Frühbeck G; Nogueiras R
    Diabetes; 2014 Oct; 63(10):3346-58. PubMed ID: 24917578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
    Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
    Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.
    Basalay MV; Mastitskaya S; Mrochek A; Ackland GL; Del Arroyo AG; Sanchez J; Sjoquist PO; Pernow J; Gourine AV; Gourine A
    Cardiovasc Res; 2016 Dec; 112(3):669-676. PubMed ID: 27702763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.
    Fortin SM; Lipsky RK; Lhamo R; Chen J; Kim E; Borner T; Schmidt HD; Hayes MR
    Sci Transl Med; 2020 Mar; 12(533):. PubMed ID: 32132220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.